Buy Gaviscon Double Action Suspension Oral Mint Vials 150 ml

Gaviscon Double Action Suspension Oral Mint Vials 150 ml

Condition: New product

1000 Items

$14.94

More info

Active ingredients

Algeldrat + Benzocaine + Magnesium hydroxide

Release form

Suspension

Pharmacological effect

The drug is a combination of two antacids (calcium carbonate, sodium bicarbonate) and sodium alginate, which has an adsorbing and enveloping effect. After taking the drug reacts quickly with gastric acid, forming a layer of alginic acid gel, which has an almost neutral pH value and covers the surface of the stomach contents, effectively preventing the manifestation of gastroesophageal reflux. In severe cases, a gel layer distributed over the surface of the stomach contents rises into the esophagus and prevents its irritation. Calcium carbonate neutralizes gastric acid and provides quick relief from digestive disorders and heartburn. This effect is enhanced by sodium bicarbonate, which also has a neutralizing effect. The total neutralizing ability of the product with a minimum dose of 10 ml is about 10 meq H +.

Pharmacokinetics

The mechanism of action of the drug is physical and does not depend on absorption into the systemic circulation.

Indications

Treatment of gastroesophageal reflux symptoms associated with the acidity of the contents of the stomach, which is thrown into the esophagus, such as sour belching, heartburn, indigestion, for example, after eating or during pregnancy.

Contraindications

The drug is contraindicated in patients with known or potentially possible sensitivity to the components of the drug.

Precautionary measures

Avoid prolonged use of the drug. If the symptoms do not disappear after 7 days, you should consult a doctor.

Use during pregnancy and lactation

Gaviscon Double-acting suspension does not affect the course of pregnancy, the condition of the fetus and newborn. The drug can be used during pregnancy and lactation.

Dosage and administration

Adults and children over the age of 12 take 10–20 ml (2–4 teaspoons) after meals and at bedtime, up to 4 times per day. Do not adjust the dose for elderly patients. Shake before use.

Side effects

Very rarely (≤1 / 10 000), as with the use of other medicines, patients with hypersensitivity to the components of the drug may experience an allergic reaction in the form of skin rash, bronchospasm, anaphylactic or anaphylactoid reactions.

Overdose

Overdose is very rare and can manifest discomfort and a feeling of bloating in the stomach. In case of overdose, it is necessary to discontinue the use of the drug and conduct symptomatic therapy.

Interaction with other drugs

Due to the presence of calcium carbonate, which acts as an antacid, it is necessary to withstand a 2-hour interval between taking Gaviscon Dual Action and other drugs, especially H2-histamine receptor blockers, tetracyclines, digoxin, fluoroquinolone, iron salts, ketaconazole, antipsychotics , penicillamine, β-adrenoreceptor blockers (atenolol, metoprolol, propranolol), GCS, chloroquine and diphosphonates.

special instructions

Every 2 pills of the drug contain 110.75 mg of sodium, and every 10 ml of suspension - 127.25 mg of sodium. This should be taken into account in patients who follow a high salt restriction diet, for example, in some cases of congestive heart failure and renal failure. Every 2 pills contain 150 mg of calcium, and every 10 ml of suspension - 130 mg of calcium. The drug should be carefully taken in patients with hypercalcemia, nephrocalcinosis and recurrent formation of calcium-containing kidney stones. Tablets: since the drug contains aspartame, it should not be prescribed to patients with phenylketonuria. Avoid prolonged use of the drug. If the symptoms do not disappear after 7 days, you should consult a doctor. The use of Gaviscon suspension. Double action, like other antacid agents, in cases of unspecified diagnosis may mask the symptoms of other diseases. Gaviskon Double-acting suspension should not be used in patients with renal insufficiency and hypophosphatemia. There is a possibility of reducing the effectiveness of the drug in patients with very low levels of gastric acidity. There is an increased risk of hypernatremia in children with gastroenteritis or suspected renal failure. Use during pregnancy and lactation.Gaviscon Double-acting suspension does not affect the course of pregnancy, the condition of the fetus and newborn. The drug can be used during pregnancy and lactation. The ability to influence the reaction rate when driving or working with other mechanisms. The drug does not affect the ability to drive vehicles and work with mechanisms. Children. As a rule, not recommended for use in children under the age of 12 years.

Reviews